Literature DB >> 15996923

Gain of function, loss of control - a molecular basis for chronic myeloproliferative disorders.

Mario Cazzola, Radek Skoda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996923

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Clinical relevance of JAK2 (V617F) mutant allele burden.

Authors:  Francesco Passamonti; Elisa Rumi
Journal:  Haematologica       Date:  2009-01       Impact factor: 9.941

Review 2.  Polycythaemia vera and essential thrombocythaemia: current treatment strategies.

Authors:  Elisabeth I Penninga; Ole W Bjerrum
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms.

Authors:  Elisa Rumi; Daniela Pietra; Paola Guglielmelli; Roberta Bordoni; Ilaria Casetti; Chiara Milanesi; Emanuela Sant'Antonio; Virginia Ferretti; Alessandro Pancrazzi; Giada Rotunno; Marco Severgnini; Alessandro Pietrelli; Cesare Astori; Elena Fugazza; Cristiana Pascutto; Emanuela Boveri; Francesco Passamonti; Gianluca De Bellis; Alessandro Vannucchi; Mario Cazzola
Journal:  Blood       Date:  2013-04-10       Impact factor: 22.113

Review 4.  The Role of MicroRNAs in Myeloproliferative Neoplasia.

Authors:  Shaban Alizadeh; Seyed Ghader Azizi; Masoud Soleimani; Yadollah Farshi; Zahra Kashani Khatib
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-07-01

5.  Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.

Authors:  Alireza Moradabadi; Alireza Farsinejad; Behzad Khansarinejad; Ahamd Fatemi
Journal:  Exp Hematol Oncol       Date:  2019-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.